Inclusion completed

A Phase Ib/II Randomized Study of BI 836845 in Combination with Exemestane and Everolimus Versus Exemestane and Everolimus Alone in Women with Locally Advanced or Metastatic Breast Cancer

Cancer type: Breast cancer

Phase: I/II

Principal Investigator: Xie Hanjing

Country: SE

Keywords: Sweden, Karolinska

Status: Inclusion completed

Link to Clinicaltrials.gov: https://clinicaltrials.gov/show/NCT02123823